Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tali Shafat

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Plos One|September 20, 2024
Outcomes of in-hospital cardiac arrest managed with and without a specialized code team: A retrospective observational studyYasmeen Abu Fraiha, Tali Shafat, Shlomi Codish, et al.
Open Forum Infectious Diseases|April 3, 2025
Outcomes and Risk Factors for Influenza and Respiratory Syncytial Virus Lower Respiratory Tract Infections and Mortality in Patients With Lymphoma or Multiple Myeloma: A 7-Year Retrospective Cohort StudyTali Shafat, Daniel De-la-Rosa-Martinez, Fareed Khawaja, et al.
Scientific Reports|July 23, 2024
Clinical outcomes of immunomodulation therapy in immunocompromised patients with severe Covid-19 and high oxygen requirementAvigayil Goldstein, Ami Neuberger, Yazeed Qassem Darawsha, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2025
Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in Immunocompromised Patients: Literature Review and Proposed Definitions for Use in Clinical TrialsRoy F Chemaly, Tali Shafat, Anna Wald, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 27, 2025
The interplay between Epstein-Barr Virus and Cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation in the era of primary CMV prophylaxisTali Shafat, Fareed Khawaja, Ying Jiang, et al.
Cancer Medicine|February 24, 2024
An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximabTali Shafat, Daniel Grupel, Tzvika Porges, et al.
Infectious Diseases and Therapy|December 9, 2024
Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter StudyHovav Azuly, Tali Shafat, Daniel Grupel, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Plos One|September 20, 2024
Outcomes of in-hospital cardiac arrest managed with and without a specialized code team: A retrospective observational studyYasmeen Abu Fraiha, Tali Shafat, Shlomi Codish, et al.
Open Forum Infectious Diseases|April 3, 2025
Outcomes and Risk Factors for Influenza and Respiratory Syncytial Virus Lower Respiratory Tract Infections and Mortality in Patients With Lymphoma or Multiple Myeloma: A 7-Year Retrospective Cohort StudyTali Shafat, Daniel De-la-Rosa-Martinez, Fareed Khawaja, et al.
Scientific Reports|July 23, 2024
Clinical outcomes of immunomodulation therapy in immunocompromised patients with severe Covid-19 and high oxygen requirementAvigayil Goldstein, Ami Neuberger, Yazeed Qassem Darawsha, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2025
Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in Immunocompromised Patients: Literature Review and Proposed Definitions for Use in Clinical TrialsRoy F Chemaly, Tali Shafat, Anna Wald, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 27, 2025
The interplay between Epstein-Barr Virus and Cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation in the era of primary CMV prophylaxisTali Shafat, Fareed Khawaja, Ying Jiang, et al.
Cancer Medicine|February 24, 2024
An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximabTali Shafat, Daniel Grupel, Tzvika Porges, et al.
Infectious Diseases and Therapy|December 9, 2024
Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter StudyHovav Azuly, Tali Shafat, Daniel Grupel, et al.
Pageof 4